SCHEMBL910513

SCHEMBL910513

CCCOc1ccccc1[C]=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP2A6 P11509 1/20 0.41
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
NLRP1 Q9C000 1/20 0.40
HTR2B P41595 2/20 0.40
HTR2C P28335 1/20 0.40
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL195415 0.91 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL2244225 0.89 CYP3A4 (0.51) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL2121850 0.87 LMNA (0.54) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL2118989 0.87 LMNA (0.54) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL6223243 0.87 LMNA (0.54) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL8453578 0.87 LMNA (0.54) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL2121240 0.87 LMNA (0.54) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL7830925 0.87 LMNA (0.54) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL2121443 0.87 LMNA (0.54) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL2123796 0.87 LMNA (0.54) CYP1A2CYP2C9CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 190 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2841111-B1 A NANOSPHERE - HISTONE ACETYLTRANSFERASE (HAT) ACTIVATOR COMPOSITION, PROCESS AND METHODS THEREOF JNCASR BANGALORE (IN) 2016-06-01 EP claimed
CN-103601641-A Glaucocalyxin derivatives and application thereof in preparation of antitumor drugs UNIV PLA 2ND MILITARY MEDICAL 2014-02-26 CN claimed
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION 2007-04-05 US claimed
US-6967197-B2 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-11-22 US claimed
CN-1188404-C Cyclic compound FUJISAWA PHARMACEUTICAL CO (JP) 2005-02-09 CN claimed
EP-1144403-B1 SUBSTITUTED PYRAZOLES AS P38 KINASE INHIBITORS SEARLE LLC (US) 2004-10-06 EP claimed
CN-1123593-C Process for increasing melt strength of polypropylene CRC FOR POLYMERS AUSTRALIA PTY (AU) 2003-10-08 CN claimed
US-6617324-B1 Phenyl, cyclohexyl and pyridinyl or pyrimidinyl-substituted G. D. SEARLE & COMPANY 2003-09-09 US claimed
US-20030134849-A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-17 US claimed
CN-1425010-A Cyclic compound FUJISAWA PHARMACEUTICAL CO (JP) 2003-06-18 CN claimed
WO-2003018019-A2 NEW USE OF CYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-06 WO claimed
US-6514977-B1 For treating p38 kinase mediated disorders G.D. SEARLE & COMPANY 2003-02-04 US claimed
EP-1259499-A1 THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-27 EP claimed
US-6423713-B1 Substituted pyrazoles as p38 kinase inhibitors G. D. SEARLE & COMPANY 2002-07-23 US claimed
CN-1342157-A Substituted pyrazoles ASP38 kinase inhibitors SEARLE & CO (US) 2002-03-27 CN claimed
EP-1144403-A1 SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-10-17 EP claimed
WO-2001060808-A1 THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-23 WO claimed
CN-1291213-A Method for improving melt strength of polypropylene CRC FOR POLYMERS PTY LTD (AU) 2001-04-11 CN claimed
WO-2000031063-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2000-06-02 WO claimed
US-10190009-B2 Ink composition, ink jet recording method using same, and colored material NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2019-01-29 US disclosed
US-9955689-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-01 US disclosed
US-9894901-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-20 US disclosed
US-9872493-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-23 US disclosed
US-20160160065-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-06-09 US disclosed
EP-3015516-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL Nippon Kayaku Kabushiki Kaisha (JP) 2016-05-04 EP disclosed
US-20150305332-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-29 US disclosed
US-20150289512-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-15 US disclosed
US-20150289506-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-15 US disclosed
US-20150282482-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-08 US disclosed
EP-2926660-A1 METHOD FOR PROMOTING PLANT GROWTH Sumitomo Chemical Company Limited (JP) 2015-10-07 EP disclosed
EP-2923573-A1 METHOD FOR PROMOTING PLANT GROWTH Sumitomo Chemical Company Limited (JP) 2015-09-30 EP disclosed
EP-2923574-A1 METHOD FOR PROMOTING PLANT GROWTH Sumitomo Chemical Company Limited (JP) 2015-09-30 EP disclosed
US-8937090-B2 Parakeratosis inhibitor, pore-shrinking agent and external composition for skin SHISEIDO COMPANY, LTD. (JP) 2015-01-20 US disclosed
CN-103601641-A Glaucocalyxin derivatives and application thereof in preparation of antitumor drugs UNIV PLA 2ND MILITARY MEDICAL 2014-02-26 CN disclosed
US-20120232111-A1 Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin SHISEIDO COMPANY, LTD. (JP) 2012-09-13 US disclosed
US-20120165409-A1 WRINKLE-IMPROVING AGENT SHISEIDO COMPANY, LTD. (JP) 2012-06-28 US disclosed
US-20110004019-A1 Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same SHISEIDO COMPANY LTD. (JP) 2011-01-06 US disclosed
EP-2255780-A1 PARAKERATOSIS INHIBITOR, PORE SHRINKING AGENT OR AGENT FOR PREVENTING OR IMPROVING ROUGH SKIN, AND COMPOSITION FOR EXTERNAL USE ON THE SKIN CONTAINING THE SAME Shiseido Company, Ltd. (JP) 2010-12-01 EP disclosed
US-20100035881-A1 WRINKLE-IMPROVING AGENT SHISEIDO COMPANY, LTD. (JP) 2010-02-11 US disclosed
US-20080275095-A1 Combination of Prostaglandin E2 Receptor Antagonists and Renin-Angiotensin System Inhibitors for Treating Renal Diseases ASTELLAS PHARMA INC. (JP) 2008-11-06 US disclosed
EP-1941861-A1 WRINKLE-IMPROVING AGENT Shiseido Company, Limited (JP) 2008-07-09 EP disclosed
EP-1880711-A1 PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT AND EXTERNAL COMPOSITION FOR SKIN Shiseido Company, Limited (JP) 2008-01-23 EP disclosed
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION 2007-04-05 US disclosed
EP-1742662-A2 COMBINATION OF PROSTAGLANDIN E2 RECEPTOR ANTAGONISTS AND RENIN-ANGIOTENSIN SYSTEM INHIBITORS FOR TREATING RENAL DISEASES Astellas Pharma Inc. (JP) 2007-01-17 EP disclosed
US-7153959-B2 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis PHARMACIA CORPORATION (US) 2006-12-26 US disclosed
US-7071198-B1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION (US) 2006-07-04 US disclosed
US-6979686-B1 Substituted pyrazoles as p38 kinase inhibitors PHARMACIA CORPORATION (US) 2005-12-27 US disclosed
US-6967197-B2 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-11-22 US disclosed
WO-2005105147-A2 COMBINATION OF PROSTAGLANDIN E2 RECEPTOR ANTAGONISTS AND RENIN-ANGIOTENSIN SYSTEM INHIBITORS FOR TREATING RENAL DISEASES ASTELLAS PHARMA INC. (JP) 2005-11-10 WO disclosed
EP-0755434-B1 DETERGENTS CONTAINING A BUILDER AND A DELAYED RELEASE ENZYME PROCTER & GAMBLE (US) 2005-03-16 EP disclosed
CN-1188404-C Cyclic compound FUJISAWA PHARMACEUTICAL CO (JP) 2005-02-09 CN disclosed
EP-1500657-A1 Substituted pyrazoles as P38 kinase inhibitors G.D. Searle LLC (US) 2005-01-26 EP disclosed
US-20040176433-A1 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis PHARMACIA CORPORATION 2004-09-09 US disclosed
CN-1123593-C Process for increasing melt strength of polypropylene CRC FOR POLYMERS AUSTRALIA PTY (AU) 2003-10-08 CN disclosed
US-6617324-B1 Phenyl, cyclohexyl and pyridinyl or pyrimidinyl-substituted G. D. SEARLE & COMPANY 2003-09-09 US disclosed
US-20030134849-A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-17 US disclosed
CN-1113952-C Detergent compositions PROCTER & GAMBLE (US) 2003-07-09 CN disclosed
CN-1425010-A Cyclic compound FUJISAWA PHARMACEUTICAL CO (JP) 2003-06-18 CN disclosed
CN-1423647-A Beta-alanine derivatives and their use as receptor antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2003-06-11 CN disclosed
US-6559113-B2 Water-soluble builder and an enzyme, wherein a means is provided for delaying the release to the wash solution of said enzyme relative to the release of said water-soluble builder THE PROCTER & GAMBLE COMPANY 2003-05-06 US disclosed
US-20030064907-A1 DETERGENTS CONTAINING A BUILDER AND A DELAYED RELEASED ENZYME PROCTER & GAMBLE COMPANY, THE 2003-04-03 US disclosed
WO-2003018019-A2 NEW USE OF CYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-06 WO disclosed
CN-1102648-C Detergents containing surfactant and delayed release peroxyacid bleach source PROCTER & GAMBLE (US) 2003-03-05 CN disclosed
US-6525059-B1 Mitogen-activated protein kinases (MAP); G. D. SEARLE & COMPANY 2003-02-25 US disclosed
US-6514977-B1 For treating p38 kinase mediated disorders G.D. SEARLE & COMPANY 2003-02-04 US disclosed
CN-1100136-C Detergent comprising builder and slow release enzyme PROCTER & GAMBLE (US) 2003-01-29 CN disclosed
EP-1259499-A1 THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-27 EP disclosed
EP-1233014-A1 ASYMMETRIC ORGANIC PEROXIDE, CROSSLINKING AGENT COMPRISING THE SAME, AND METHOD OF CROSSLINKING WITH THE SAME NOF CORPORATION (JP) 2002-08-21 EP disclosed
US-6437146-B1 MESANGIAL PROLIFERATIVE GLOMERULONEPHRITIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-08-20 US disclosed
US-6423713-B1 Substituted pyrazoles as p38 kinase inhibitors G. D. SEARLE & COMPANY 2002-07-23 US disclosed
CN-1083000-C Detergent containing surfactant and delayed release enzyme PROCTER & GAMBLE (US) 2002-04-17 CN disclosed
CN-1083004-C Bleach compositions comprising protease enzyme PROCTER & GAMBLE (US) 2002-04-17 CN disclosed
CN-1342157-A Substituted pyrazoles ASP38 kinase inhibitors SEARLE & CO (US) 2002-03-27 CN disclosed
CN-1336952-A Detergent compositions comprising pectate lyase and a blench system PROCTER & GAMBLE (US) 2002-02-20 CN disclosed
CN-1328550-A Oxazole compounds as prostaglandin E2 agonists or antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-12-26 CN disclosed
EP-0714898-B1 PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE OTSUKA PHARMA CO LTD (JP) 2001-11-14 EP disclosed
US-6313086-B1 GRANULAR DETERGENT COMPOSITION COMPRISING SULFATE SALT, ACID DISPERSING AID AND ALKALI SOURCE, WHICH HAVE SPECIFIED PARTICLE SIZE AND ARE CAPABLE OF REACTING TOGETHER IN PRESENCE OF WATER TO PRODUCE GAS THE PROCTER & GAMBLE COMPANY 2001-11-06 US disclosed
EP-1144403-A1 SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-10-17 EP disclosed
EP-1141200-A1 DETERGENT COMPOSITIONS COMPRISING A PECTATE LYASE AND A BLEACH SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2001-10-10 EP disclosed
WO-2001060808-A1 THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-23 WO disclosed
EP-0706559-B1 MACHINE DISHWASHING COMPOSITION CONTAINING OXYGEN BLEACH AND PARAFFIN OIL AND BENZOTRIAZOLE COMPOUND SILVER TARNISHING INHIBITORS PROCTER & GAMBLE (US) 2001-08-08 EP disclosed
WO-2000042156-A9 DETERGENT COMPOSITIONS COMPRISING A PECTATE LYASE AND A BLEACH SYSTEM PROCTER & GAMBLE (US) 2001-06-28 WO disclosed
CN-1066715-C Bleaching compounds comprising substituted benzoyl caprolactam bleach activators PROCTER & GAMBLE (US) 2001-06-06 CN disclosed
CN-1066194-C Bleaching compositions comprising bleach activators and bleach catalysts PROCTER & GAMBLE (US) 2001-05-23 CN disclosed
US-6221430-B1 SPRAYING AN AQUEOUS BINDER MIXTURE; DRYING THE PROCTER & GAMBLE COMPANY 2001-04-24 US disclosed
CN-1291213-A Method for improving melt strength of polypropylene CRC FOR POLYMERS PTY LTD (AU) 2001-04-11 CN disclosed
WO-2000042156-A1 DETERGENT COMPOSITIONS COMPRISING A PECTATE LYASE AND A BLEACH SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2000-07-20 WO disclosed
WO-2000042150-A1 DETERGENT COMPOSITIONS COMPRISING A PECTATE LYASE AND A METAL BLEACH CATALYST THE PROCTER & GAMBLE COMPANY (US) 2000-07-20 WO disclosed
WO-2000031063-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2000-06-02 WO disclosed
EP-0915949-A4 DETERGENT COMPOSITIONS PROCTER & GAMBLE (US) 2000-01-26 EP disclosed
EP-0929622-A4 DETERGENT COMPOSITIONS PROCTER & GAMBLE (US) 2000-01-05 EP disclosed
EP-0763096-B1 BLEACH COMPOSITIONS COMPRISING OLEOYL SARCOSINATE SURFACTANTS PROCTER & GAMBLE (US) 1999-12-15 EP disclosed
EP-0756622-B1 BLEACH COMPOSITIONS COMPRISING PROTEASE ENZYME PROCTER & GAMBLE (US) 1999-12-15 EP disclosed
CN-1238798-A Detergent compositions PROCTER & GAMBLE (US) 1999-12-15 CN disclosed
EP-0912703-A4 DETERGENT COMPOSITIONS PROCTER & GAMBLE (US) 1999-12-01 EP disclosed
CN-1046730-C Pyrazolo [1,5-a ] pyrimidine derivatives OTSUKA PHARMA CO LTD (JP) 1999-11-24 CN disclosed
US-5932532-A LAUNDRY DETERGENT PROCTER & GAMBLE COMPANY (US) 1999-08-03 US disclosed
EP-0929622-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-07-21 EP disclosed
EP-0795004-A4 MACHINE DISHWASHING DETERGENT COMPOSITIONS CONTAINING SILICATE MIXTURES PROCTER & GAMBLE (US) 1999-06-30 EP disclosed
EP-0794999-A4 NON-TARNISHING MACHINE DISHWASHING DETERGENT CONTAINING OXYGEN BLEACH, METASILICATE AND HIGHER SILICA RATIO SILICATE PROCTER & GAMBLE (US) 1999-06-30 EP disclosed
EP-0906406-A4 BLEACHING COMPOSITION COMPRISING METAL CATALYST, CELLULASE ENZYME, AND OXYGEN BLEACH PROCTER & GAMBLE (US) 1999-06-16 EP disclosed
EP-0915949-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-05-19 EP disclosed
EP-0912703-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-05-06 EP disclosed
EP-0906406-A1 BLEACHING COMPOSITION COMPRISING METAL CATALYST, CELLULASE ENZYME, AND OXYGEN BLEACH THE PROCTER & GAMBLE COMPANY (US) 1999-04-07 EP disclosed
WO-1999015524-A1 THIAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-04-01 WO disclosed
US-5856334-A ANTAGONIST FOR EOSINOPHILS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1999-01-05 US disclosed
EP-0755431-A4 DETERGENTS CONTAINING A BUILDER AND A DELAYED RELEASE PEROXYACID BLEACH SOURCE PROCTER & GAMBLE (US) 1998-12-23 EP disclosed
EP-0755433-A4 DETERGENTS CONTAINING A SURFACTANT AND A DELAYED RELEASE ENZYME PROCTER & GAMBLE (US) 1998-12-23 EP disclosed
CN-1200758-A Bleach compositions comprising oleoyl sarcosinate surfactants PROCTER & GAMBLE (US) 1998-12-02 CN disclosed
EP-0754219-B1 BLEACH COMPOSITIONS COMPRISING BLEACH ACTIVATORS AND BLEACH CATALYSTS PROCTER & GAMBLE (US) 1998-09-09 EP disclosed
EP-0755434-A4 DETERGENTS CONTAINING A BUILDER AND A DELAYED RELEASE ENZYME PROCTER & GAMBLE (US) 1998-07-29 EP disclosed
WO-1998013448-A9 DETERGENT COMPOSITIONS 1998-07-09 WO disclosed
US-5755992-A MIXED WITH POLYMERIC DYE TRANSFER INHIBITOR; ANTISOILANT PRETREATMENT WASH THE PROCTER & GAMBLE COMPANY (US) 1998-05-26 US disclosed
WO-1998013448-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-04-02 WO disclosed
EP-0705326-B1 ACYL VALEROLACTAM BLEACH ACTIVATORS PROCTER & GAMBLE (US) 1998-03-11 EP disclosed
WO-1998004661-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-02-05 WO disclosed
US-5707997-A ANALGESICS OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1998-01-13 US disclosed
US-5698504-A CONSISTS OF AN OXYGEN RELEASING AGENT, PARAFFIN OIL AND BENZOTRIAZOLE COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1997-12-16 US disclosed
US-5695679-A CONTROLLED RELEASE OXYGEN RELEASING BLEACHING AGENT, NONPARAFFIN OIL FATTY ACID ESTER SILVER COATING AGENT COMPRISING GLYCERIDES; NONTARNISHING THE PROCTER & GAMBLE COMPANY (US) 1997-12-09 US disclosed
WO-1997045524-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-12-04 WO disclosed
WO-1997036920-A1 BUILDER MATERIAL THE PROCTER & GAMBLE COMPANY (US) 1997-10-09 WO disclosed
WO-1997034985-A1 BLEACHING COMPOSITION COMPRISING METAL CATALYST, CELLULASE ENZYME, AND OXYGEN BLEACH THE PROCTER & GAMBLE COMPANY (US) 1997-09-25 WO disclosed
EP-0795004-A1 MACHINE DISHWASHING DETERGENT COMPOSITIONS CONTAINING SILICATE MIXTURES THE PROCTER & GAMBLE COMPANY (US) 1997-09-17 EP disclosed
EP-0794999-A1 NON-TARNISHING MACHINE DISHWASHING DETERGENT CONTAINING OXYGEN BLEACH, METASILICATE AND HIGHER SILICA RATIO SILICATE THE PROCTER & GAMBLE COMPANY (US) 1997-09-17 EP disclosed
CN-1151179-A bleaching compositions comprising protease PROCTER & GAMBLE (US) 1997-06-04 CN disclosed
CN-1150818-A Detergent comprising surfactant and slow release peroxyacid bleach source PROCTER & GAMBLE (US) 1997-05-28 CN disclosed
CN-1150817-A Detergents containing builder and delayed release enzyme PROCTER & GAMBLE (US) 1997-05-28 CN disclosed
CN-1150454-A Detergents containing surfactant and delayed release enzyme PROCTER & GAMBLE (US) 1997-05-21 CN disclosed
CN-1150453-A Detergent containing builder and delayed release peroxyacid bleach source PROCTER & GAMBLE (US) 1997-05-21 CN disclosed
EP-0773219-A1 IMIDAZOQUINOLINE DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1997-05-14 EP disclosed
CN-1149886-A Bleach compositions comprising bleach activators and bleach catalysts PROCTER & GAMBLE (US) 1997-05-14 CN disclosed
EP-0763096-A1 BLEACH COMPOSITIONS COMPRISING OLEOYL SARCOSINATE SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1997-03-19 EP disclosed
EP-0756622-A1 BLEACH COMPOSITIONS COMPRISING PROTEASE ENZYME THE PROCTER & GAMBLE COMPANY (US) 1997-02-05 EP disclosed
EP-0755434-A1 DETERGENTS CONTAINING A BUILDER AND A DELAYED RELEASE ENZYME THE PROCTER & GAMBLE COMPANY (US) 1997-01-29 EP disclosed
EP-0755431-A1 DETERGENTS CONTAINING A BUILDER AND A DELAYED RELEASE PEROXYACID BLEACH SOURCE THE PROCTER & GAMBLE COMPANY (US) 1997-01-29 EP disclosed
EP-0755433-A1 DETERGENTS CONTAINING A SURFACTANT AND A DELAYED RELEASE ENZYME THE PROCTER & GAMBLE COMPANY (US) 1997-01-29 EP disclosed
EP-0726933-A4 DETERGENT COMPOSITIONS PROCTER & GAMBLE (US) 1997-01-22 EP disclosed
EP-0754219-A1 BLEACH COMPOSITIONS COMPRISING BLEACH ACTIVATORS AND BLEACH CATALYSTS THE PROCTER & GAMBLE COMPANY (US) 1997-01-22 EP disclosed
EP-0737739-A2 Process for making a detergent particle THE PROCTER & GAMBLE COMPANY (US) 1996-10-16 EP disclosed
CN-1131948-A Pyrazolo [1, 5-a ] pyrimidine derivatives OTSUKA PHARMA CO LTD (JP) 1996-09-25 CN disclosed
EP-0726933-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1996-08-21 EP disclosed
WO-1996017051-A1 MACHINE DISHWASHING DETERGENT COMPOSITIONS CONTAINING SILICATE MIXTURES THE PROCTER & GAMBLE COMPANY (US) 1996-06-06 WO disclosed
WO-1996017046-A1 NON-TARNISHING MACHINE DISHWASHING DETERGENT CONTAINING OXYGEN BLEACH, METASILICATE AND HIGHER SILICA RATIO SILICATE THE PROCTER & GAMBLE COMPANY (US) 1996-06-06 WO disclosed
EP-0714898-A1 PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1996-06-05 EP disclosed
CN-1124025-A Bleaching compounds comprising substituted benzoyl caprolactam bleach activators PROCTER & GAMBLE (US) 1996-06-05 CN disclosed
EP-0710713-A2 Bleaching compositions THE PROCTER & GAMBLE COMPANY (US) 1996-05-08 EP disclosed
EP-0710714-A2 Bleaching compositions THE PROCTER & GAMBLE COMPANY (US) 1996-05-08 EP disclosed
EP-0323441-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1996-04-24 EP disclosed
EP-0706559-A4 1996-04-24 EP disclosed
EP-0706559-A1 MACHINE DISHWASHING COMPOSITION CONTAINING OXYGEN BLEACH AND PARAFFIN OIL AND BENZOTRIAZOLE COMPOUND SILVER TARNISHING INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1996-04-17 EP disclosed
EP-0705326-A1 ACYL VALEROLACTAM BLEACH ACTIVATORS THE PROCTER & GAMBLE COMPANY (US) 1996-04-10 EP disclosed
US-5503639-A WITHOUT DAMAGE TO NATURAL RUBBER PARTS THE PROCTER & GAMBLE COMPANY (US) 1996-04-02 US disclosed
EP-0690122-A2 Detergent compositions THE PROCTER & GAMBLE COMPANY (US) 1996-01-03 EP disclosed
WO-1995033043-A1 BLEACH COMPOSITIONS COMPRISING OLEOYL SARCOSINATE SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1995-12-07 WO disclosed
EP-0682105-A2 Bleaching compositions THE PROCTER & GAMBLE COMPANY (US) 1995-11-15 EP disclosed
WO-1995029225-A1 BLEACH COMPOSITIONS COMPRISING PROTEASE ENZYME THE PROCTER & GAMBLE COMPANY (US) 1995-11-02 WO disclosed
WO-1995028465-A1 DETERGENTS CONTAINING A BUILDER AND A DELAYED RELEASE PEROXYACID BLEACH SOURCE THE PROCTER & GAMBLE COMPANY (US) 1995-10-26 WO disclosed
WO-1995028466-A1 DETERGENTS CONTAINING A SURFACTANT AND A DELAYED RELEASE ENZYME THE PROCTER & GAMBLE COMPANY (US) 1995-10-26 WO disclosed
WO-1995028469-A1 DETERGENTS CONTAINING A BUILDER AND A DELAYED RELEASE ENZYME THE PROCTER & GAMBLE COMPANY (US) 1995-10-26 WO disclosed
WO-1995027773-A1 BLEACH COMPOSITIONS COMPRISING BLEACH ACTIVATORS AND BLEACH CATALYSTS THE PROCTER & GAMBLE COMPANY (US) 1995-10-19 WO disclosed
EP-0672749-A1 Bleaching compositions THE PROCTER & GAMBLE COMPANY (US) 1995-09-20 EP disclosed
EP-0436902-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1995-06-28 EP disclosed
WO-1995012652-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1995-05-11 WO disclosed
US-5405413-A Peroxygen bleaching compounds THE PROCTER & GAMBLE CO. (US) 1995-04-11 US disclosed
WO-1995001416-A1 MACHINE DISHWASHING COMPOSITION CONTAINING OXYGEN BLEACH AND PARAFFIN OIL AND BENZOTRIAZOLE COMPOUND SILVER TARNISHING INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1995-01-12 WO disclosed
WO-1995000626-A1 BLEACHING COMPOUNDS COMPRISING ACYL VALEROLACTAM BLEACH ACTIVATORS THE PROCTER & GAMBLE COMPANY (US) 1995-01-05 WO disclosed
US-5306719-A Cardiotonic agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-04-26 US disclosed
EP-0247381-B1 5-FLUROROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-08-04 EP disclosed
EP-0255134-B1 CARBOSTYRIL DERIVATIVES AND SALTS THEREOF, PROCESS FOR PREPARING THEM, AND CARDIOTONIC COMPOSITION CONTAINING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-03 EP disclosed
US-5162305-A Calcium lowering in blood; hypoglycemic agents, analgesics OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-10 US disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
US-5071856-A CARBOSTYRIL DERIVATIVES AND SALTS THEREOF OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-12-10 US disclosed
US-5047521-A Anticarcinogenic agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-09-10 US disclosed
EP-0180897-B1 5-FLUOROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-07 EP disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
US-4886809-A CARDIOTONIC AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-12-12 US disclosed
CN-1036582-A The preparation method of polypeptide derivative OTSUKA CHEMICAL CO LTD (JP) 1989-10-25 CN disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0330241-A2 Calcitonin derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-08-30 EP disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
EP-0255134-A2 Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-02-03 EP disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0058341-B1 AZEPINE DERIVATIVES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1985-05-15 EP disclosed
US-4438277-A Hydronaphthalene derivatives SANKYO COMPANY, LIMITED (JP) 1984-03-20 US disclosed
US-4414225-A Azepine derivatives and their anti-thrombotic compositions and methods DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-11-08 US disclosed
US-4361515-A Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use SANKYO COMPANY, LIMITED (JP) 1982-11-30 US disclosed
EP-0058341-A1 Azepine derivatives, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1982-08-25 EP disclosed
EP-0058341-A1 Azepine derivatives, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1982-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035881-A1 WRINKLE-IMPROVING AGENT AAAS, GLA, COL14A1 CYP1A2 3833/4885CYP2C9 4495/4885CYP2C19 4474/4885
US-20080275095-A1 Combination of Prostaglandin E2 Receptor Antagonists and Renin-Angiotensin System Inhibitors for Treating Renal Diseases AGTR2, REN, AGTR1 CYP1A2 340/4885CYP2C9 996/4885CYP2C19 431/4885
US-20150289506-A1 METHOD FOR PROMOTING PLANT GROWTH FGF2, BROX, BOLA2; BOLA2B CYP1A2 824/4885CYP2C9 1941/4885CYP2C19 2787/4885
US-20150305332-A1 METHOD FOR PROMOTING PLANT GROWTH FGF1, BROX, FGF2 CYP1A2 1188/4885CYP2C9 1306/4885CYP2C19 1754/4885
US-20040176433-A1 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis MAPK1, IL1R1, TNF CYP1A2 231/4885CYP2C9 1955/4885CYP2C19 1252/4885
US-20120232111-A1 Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin CUTA, AAAS, NUP160 CYP1A2 3980/4885CYP2C9 4638/4885CYP2C19 4494/4885
US-20110004019-A1 Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same CUTA, GLRA3, ARGLU1 CYP1A2 4699/4885CYP2C9 4868/4885CYP2C19 4771/4885
US-20120165409-A1 WRINKLE-IMPROVING AGENT AAAS, GLA, COL14A1 CYP1A2 3658/4885CYP2C9 4491/4885CYP2C19 4454/4885
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma MAPK1, MAPK3, MAPK4 CYP1A2 1069/4885CYP2C9 3826/4885CYP2C19 3141/4885
US-20030134849-A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors MMP9, MMP1, MMP3 CYP1A2 2174/4885CYP2C9 2162/4885CYP2C19 2839/4885
US-20150282482-A1 METHOD FOR PROMOTING PLANT GROWTH BOLA2; BOLA2B, BROX, TET1 CYP1A2 517/4885CYP2C9 1728/4885CYP2C19 2454/4885
US-20150289512-A1 METHOD FOR PROMOTING PLANT GROWTH FGF1, MKI67, FGF2 CYP1A2 305/4885CYP2C9 2378/4885CYP2C19 2000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.